Repligen Stock (RGEN)
Track Repligen stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
RGEN
Repligen
healthcare
$123.77
▼ -9.37 (-7.65%) past year
Market Cap
$6.50B
P/E Ratio
199.2x
1Y Return
-7.65%
EPS (TTM)
$0.91
Read the latest TheStreet Pro articles mentioning Repligen, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
1 articleDaily Diary Mentions
0 mentionsNo diary mentions for RGEN yet.